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NATIONAL
TRENDS
While U.S. women, compared to men,
are less likely to die of a drug overdose
(Mazure & Fiellin, 2018), the rate of
overdose deaths among women is
rapidly increasing, narrowing the
gender gap in overdose deaths (CDC,
2018a). Women experienced a 532%
increase in fatal opioid overdose
deaths between 1999 and 2017,
compared to a 355% increase for men
(CDC, 2018a). Among women, those in
rural areas have disproportionately
higher drug overdose death rates than
women in urban areas (Mazure &
Fiellin, 2018), indicating an opportunity
for targeted rural public health
interventions to slow overdose fatality
increases among women.
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UTAH TRENDS
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Between 1999 and 2017, women in Utah
mirrored national trends with a
disproportionately high increase in opioid
overdose deaths. Overdose deaths
increased by 243% among Utah women,
while deaths rose only 63% among men
(CDC, 2018a). From 2013 to 2017, Utah’s
rural areas experienced some of the
highest rates of drug-induced mortality.
According to the Centers for Disease
Control and Prevention (CDC, 2018a), the
top three highest rates (per 100,000) of
overdose deaths occurred in the following
rural counties: Carbon, 47.6; Tooele, 20.6;
Sanpete, 19.0.
Three counties in Utah, all of which are 
rural, reported higher rates of opioid
overdose among women than among
men: Juab, Uintah, and Sevier (CDC,
2018a), the former two housing reservation
lands as well (USDA, 2019). Of the
remaining rural counties, many do not
have sufficient data to report reliable
numbers (CDC, 2018a). Other barriers, such
as stigma regarding opioid use and
medication-assisted treatment, may
obscure the full extent of the issue (Olsen
& Sharfstein, 2014). As a result, it is difficult
to determine the exact number of rural




FATALITIES  AMONG  WOMEN
Shorter duration between the start of
opioid use and diagnosed addiction
than men (Back, Payne, Wahlquist et
al., 2011; Hernandez-Avila, Rounsaville,
& Kranzler, 2004). 
More likelihood than men to be
prescribed an opioid and a higher
dose of that opioid (Darnall, Stacey, &
Chou, 2012).
Greater addiction severity (HCUP,
2019). 
Features of opioid use disorder differ by
gender. For example, women experience:
Also, trauma enhances risk for opioid use
disorders among women more strongly
than men (Hemsing, Greaves, Poole, &
Schmidt, 2016), and post-traumatic stress
disorder (PTSD) due to physical and 
sexual trauma (including intimate partner
violence [IPV]) is more common among
women with addictions than men (NIDA,
2012). Furthermore, PTSD is positively
associated with opioid misuse (McCauley,
Amstadter, Danielson, Ruggiero,
Kilpatrick, & Resnick, 2009). Women who
are victims of IPV are at greater risk of
misusing opioids (Cole, & Logan, 2010;
McCauley, Amstadter, Danielson,
Ruggiero, Kilpatrick, & Resnick, 2009), and
opioid misuse is associated with higher
risk of overdose and death (Hemsing,
Greaves, Poole, & Schmidt, 2016).
Although research investigating
connections between IPV and opioid use
disorder is limited, the more general
association between substance use
disorders and IPV is thoroughly
documented.
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Intimate partner violence is defined as physical, sexual, or psychological violence
inflicted by a current or past intimate partner (CDC, 2018b). Problematic drug use
(including problematic opioid use) is significantly associated with both perpetration
of IPV (male partner to female partner) and IPV victimization (of the female partner),
and females who use substances are more likely than male counterparts to be
victims of IPV (Cafferky, Mendez, Anderson, & Stith, 2018; Gilbert, El-Bassel, Chang,
Shaw, Wu, & Roy, 2013). 
While substance use both exacerbates and increases the risk of IPV occurring (Moore,
Easton, & McMahon, 2011; Smith, Homish, Leonard, & Cornelius, 2012), what many do
not realize is that substance use is a common coping response among people being
victimized by violence (Cafferky, Mendez, Anderson, & Stith, 2018). Substance use
among perpetrators can also exacerbate the severity of IPV (El-Bassel, Gilbert, Wu,
Chang, & Fontdevila, 2007; Moore, Easton, & McMahon, 2011). Unfortunately, women
living in rural areas often have higher rates of unmet service needs, such as access to
healthcare and treatment (Karra, Fink, & Canning, 2017; Nicholl, West, Goodacre, &
Turner, 2007; Raknes, Hansen, & Hunskaar, 2013; Stulz, Pichler, Kawohl, & Hepp, 2018).
This unmet access puts women at increased risk of both substance use disorders and
IPV (Gilbert, El-Bassel, Chang, Shaw, Wu, & Roy, 2013).
INTIMATE  PARTNER  VIOLENCE
AND  SUBSTANCE  USE
DISORDERS







Any healthcare professional licensed to prescribe medications can prescribe Naltrexone.
Naloxone
https://naloxone.utah.gov
Harm Reduction Services, Education, and Advocacy
https://utahharmreduction.org/
Community Abuse Prevention Service Agency
24-hour Crisis Hotline: 435-753-2500
https://www.capsa.org/
Center for Disease Control and Prevention
https://www.cdc.gov/violenceprevention/intimatepartnerviolence/index.html
Preventing Intimate Partner Violence
https://www.cdc.gov/violenceprevention/intimatepartnerviolence/fastfact.html
Office on Women’s Health
https://www.womenshealth.gov/relationships-and-safety/domestic-violence
National Domestic Violence Hotline
1-800-799-7233 or TTY 1-800-787-3224
Secure online chat:  https://www.thehotline.org/what-is-live-chat/
Utah Domestic Violence Coalition
124 South 400 East, Suite 300, Salt Lake City, UT 84111; (801) 521-5544
www.udvc.org
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If you or someone you love is experiencing or has experienced an opioid use disorder,
and/or IPV, here are some resources to help.
RESOURCES
Overdose rates are increasing
dramatically among women.
There is an association between
intimate partner violence and
substance use disorders.
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There are state and national 
resources to assist women 
experiencing opioid use disorder 
and intimate partner violence.
P A G E  1 0  
REFERENCES
Back, S.E., Payne, R.L., Wahlquist, A.H., Carter, R.E., Stroud, Z., Haynes, L, Hillhouse, M, Brady, K.T., & Ling, W.
(2011). Comparative profiles of men and women with opioid dependence: Results from a national multisite
effectiveness trial. American Journal of Drug and Alcohol Abuse, 37(5), 313–323.
doi:10.3109/00952990.2011.596982
Cafferky, B.M., Mendez, M., Anderson, J.R., & Stith, S.M. (2018). Substance use and intimate partner violence: A
meta-analytic review. Psychology of Violence, 8(1), 110–131. doi:10.1037/vio0000074
Centers for Disease Control and Prevention (CDC). (2018a). Multiple cause of death 1999–2019. CDC WONDER
Online Database. Retrieved February 18, 2019 from http://wonder.cdc.gov/mcd-icd10.html. 
Center for Disease Control and Prevention (CDC). (2018b). Intimate partner violence. Injury Center, Violence
Prevention. https://www.cdc.gov/violenceprevention/intimatepartnerviolence/index.html
Cole, J., & Logan, T. K. (2010). Nonmedical use of sedative-hypnotics and opiates among rural and urban women
with protective orders. Journal of Addictive Diseases, 29(3), 395–409.
Darnall, B. D., Stacey, B. R., & Chou, R. (2012). Medical and psychological risks and consequences of long-term
opioid therapy in women. Pain Medicine, 13(9), 1181–1211.
El-Bassel, N., Gilbert, L., Wu, E., Chang, M., & Fontdevila, J. (2007). Perpetration of intimate partner violence
among men in methadone treatment programs in New York City. American Journal of Public Health, 97(7),
1230-1232. doi:10.2105/AJPH.2006.090712
Gilbert, L., El‐Bassel, N., Chang, M., Shaw, S. A., Wu, E., & Roy, L. (2013). Risk and protective factors for drug use
and partner violence among women in emergency care. Journal of Community Psychology, 41(5), 565–581.
Healthcare Cost and Utilization Project (HCUP). (2019). Opioid hospital stays/emergency department visits -
HCUP fast stats. Retrieved August 6, 2019 from https://www.hcup-us.ahrq.gov. 
Hemsing, N., Greaves, L., Poole, N., & Schmidt, R. (2016). Misuse of Prescription Opioid Medication among
Women: A Scoping Review. Pain Research and Management. doi:10.1155/2016/1754195
Hernandez-Avila, C.A., Rounsaville, B.J., & Kranzler, H.R. (2004). Opioid-, cannabis- and alcohol-dependent
women show more rapid progression to substance abuse treatment. Drug and Alcohol Dependence, 74(3), 265–
272. doi:10.1016/j.drugalcdep.2004.02.001
Karra, M., Fink, G., & Canning, D. (2017). Facility distance and child mortality: A multi-country study of health
facility access, service utilization, and child health outcomes. International Journal of Epidemiology, 46(3), 817–
826.
Mazure, C.M., & Fiellin, D.A. (2018). Women and opioids: something different is happening here. The Lancet,
392(10141), 9–11.
McCauley, J. L., Amstadter, A. B., Danielson, C. K., Ruggiero, K. J., Kilpatrick, D. G., & Resnick, H. S. (2009). Mental
health and rape history in relation to non-medical use of prescription drugs in a national sample of women.
Addictive Behaviors, 34(8), 641–648.
Moore, B.C., Easton, C.J., & McMahon, T.J. (2011). Drug abuse and intimate partner violence: A comparative study
of opioid-dependent fathers. American Journal of Orthopsychiatry, 81(2), 218–227.
National Institute of Drug Abuse (NIDA). (2012). Principles of drug addiction treatment: A research-based guide
(NIH Publication No. 12-4180). U.S. Department of Health and Human Services, National Institute of Health.
https://www.drugabuse.gov
O F F I C E  O F  H E A L T H  E Q U I T Y  AND  C OMMUN I T Y  E N G A G EM E N T
THIS MANUSCRIPT IS MADE POSSIBLE BY SAMHSA GRANT AWARD #1H79TI081890-01.
In its programs and activities, Utah State University does not discriminate based on race, color, religion, sex,
national origin, age, genetic information, sexual orientation or gender identity/expression, disability, status as a
protected veteran, or any other status protected by University policy or local, state, or federal law. The following
individuals have been designated to handle inquiries regarding non-discrimination policies: Executive Director
of the Office of Equity, Alison Adams-Perlac, alison.adams-perlac@usu.edu, Title IX Coordinator, Hilary
Renshaw, hilary.renshaw@usu.edu, Old Main Rm. 161, 435-797-1266. For further information on notice of non-
discrimination: U.S. Department of Education, Office for Civil Rights, 303-844-5695, OCR.Denver@ed.gov. Issued
in furtherance of Cooperative Extension work, acts of May 8 and June 30, 1914, in cooperation with the U.S.
Department of Agriculture, Kenneth L. White, Vice President for Extension and Agriculture, Utah State
University.
Nicholl, J., West, J., Goodacre, S., & Turner, J. (2007). The relationship between distance to hospital and patient
mortality in emergencies: An observational study. Emergency Medicine Journal (EMJ), 24(9), 665–668.
doi:10.1136/emj.2007.047654
Olsen, Y., & Sharfstein, J. M. (2014). Confronting the stigma of opioid use disorder—and its treatment. Journal of
the American Medical Association (JAMA), 311(14), 1393–1394.
Raknes, G., Hansen, E. H., & Hunskaar, S. (2013). Distance and utilisation of out-of-hours services in a Norwegian
urban/rural district: an ecological study. BMC Health Services Research, 13(1). doi: 10.1186/1472-6963-13-222
Smith, P. H., Homish, G. G., Leonard, K. E., & Cornelius, J. R. (2012). Intimate partner violence and specific
substance use disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
Psychology of Addictive Behaviors, 26(2), 236.
Stulz, N., Pichler, E.-M., Kawohl, W., & Hepp, U. (2018). The gravitational force of mental health services: distance
decay effects in a rural Swiss service area. BMC Health Services Research, 18(1). doi: 10.1186/s12913-018-2888-1
United States Department of Agricultural Economic Research Service (USDA-ERS). (2019). What is rural?
Retrieved Jan. 30, 2020 from https://www.ers.usda.gov/topics/rural-economy-population/rural-
classifications/what-is-rural/
